U.S. Physical Therapy, Inc. (NYSE:USPH) Short Interest Down 5.7% in November

Share on StockTwits

U.S. Physical Therapy, Inc. (NYSE:USPH) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,150,000 shares, a decline of 5.7% from the October 31st total of 1,220,000 shares. Based on an average trading volume of 87,900 shares, the days-to-cover ratio is currently 13.1 days. Currently, 9.2% of the shares of the company are short sold.

Several brokerages have issued reports on USPH. Barrington Research raised shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price objective on the stock in a research note on Friday, November 8th. Zacks Investment Research cut shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Thursday, November 28th. Finally, ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. One research analyst has rated the stock with a sell rating and three have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $127.20.

Shares of NYSE USPH opened at $113.03 on Tuesday. The firm has a market capitalization of $1.49 billion, a P/E ratio of 42.65, a PEG ratio of 3.33 and a beta of 1.05. U.S. Physical Therapy has a one year low of $98.69 and a one year high of $148.48. The company’s fifty day moving average is $128.07 and its two-hundred day moving average is $126.55. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.47 and a current ratio of 1.47.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, November 7th. The company reported $0.71 EPS for the quarter, hitting the consensus estimate of $0.71. The company had revenue of $117.30 million for the quarter, compared to analyst estimates of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. The business’s revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.64 EPS. On average, sell-side analysts forecast that U.S. Physical Therapy will post 2.86 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 18th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.06%. U.S. Physical Therapy’s dividend payout ratio is presently 45.28%.

In other U.S. Physical Therapy news, Director Mark J. Brookner sold 1,000 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $116.00, for a total value of $116,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Lawrance W. Mcafee sold 1,598 shares of the business’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $113.52, for a total transaction of $181,404.96. The disclosure for this sale can be found here. Insiders sold a total of 4,476 shares of company stock worth $515,700 over the last ninety days. Corporate insiders own 2.50% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. NumerixS Investment Technologies Inc purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth about $61,000. Ladenburg Thalmann Financial Services Inc. boosted its position in shares of U.S. Physical Therapy by 74.0% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 548 shares of the company’s stock worth $67,000 after buying an additional 233 shares in the last quarter. Tower Research Capital LLC TRC purchased a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth about $91,000. Resources Investment Advisors LLC. boosted its position in shares of U.S. Physical Therapy by 96.6% in the 2nd quarter. Resources Investment Advisors LLC. now owns 816 shares of the company’s stock worth $100,000 after buying an additional 401 shares in the last quarter. Finally, Nisa Investment Advisors LLC purchased a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth about $214,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: How mutual funds make money

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.